Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Reading the DNA of fetuses is the next frontier of the genome revolution. Do you really want to know the genetic destiny of your unborn child?
Companies count DNA sequences in the blood of high-risk moms to test for Down syndrome and other large-scale disruptions, but they could do more.
The blood tests may herald a new wave of noninvasive prenatal screening.
New technologies aim to reduce the risks and improve the accuracy of prenatal genetic tests.
A new blood test uses scraps of fetal DNA to piece together a prenatal diagnosis.
Enhancing specific chemical signaling in the brain could help treat the disorder.
Customized Down syndrome stem cells reveal a way to starve tumors.
New embryo-screening technologies could weed out embryos with major genetic abnormalities and improve IVF success rates.